tetano
Editor, Senior Moderator
Immunity
. 2023 Nov 14;56(11):2463-2465.
doi: 10.1016/j.immuni.2023.10.012. Illuminating the dark side of neuraminidase in influenza immunity
Gregory C Ippolito[SUP] 1 [/SUP]
Affiliations
The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.
. 2023 Nov 14;56(11):2463-2465.
doi: 10.1016/j.immuni.2023.10.012. Illuminating the dark side of neuraminidase in influenza immunity
Gregory C Ippolito[SUP] 1 [/SUP]
Affiliations
- PMID: 37967527
- DOI: 10.1016/j.immuni.2023.10.012
The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.